124 related articles for article (PubMed ID: 17970784)
1. Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6.
Yumita N; Han QS; Kitazumi I; Umemura S
Cancer Sci; 2008 Jan; 99(1):166-72. PubMed ID: 17970784
[TBL] [Abstract][Full Text] [Related]
2. Sonodynamically induced apoptosis and active oxygen generation by gallium-porphyrin complex, ATX-70.
Yumita N; Okudaira K; Momose Y; Umemura S
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1071-8. PubMed ID: 20204369
[TBL] [Abstract][Full Text] [Related]
3. Sonodynamically induced apoptosis with porfimer sodium in HL-60 cells.
Yumita N; Han QS; Umemura S
Anticancer Drugs; 2007 Nov; 18(10):1149-56. PubMed ID: 17893515
[TBL] [Abstract][Full Text] [Related]
4. Involvement of reactive oxygen species in sonodynamically induced apoptosis using a novel porphyrin derivative.
Yumita N; Iwase Y; Nishi K; Komatsu H; Takeda K; Onodera K; Fukai T; Ikeda T; Umemura S; Okudaira K; Momose Y
Theranostics; 2012; 2(9):880-8. PubMed ID: 23082100
[TBL] [Abstract][Full Text] [Related]
5. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6).
Yumita N; Iwase Y; Nishi K; Ikeda T; Komatsu H; Fukai T; Onodera K; Nishi H; Takeda K; Umemura S; Okudaira K; Momose Y
Anticancer Res; 2011 Feb; 31(2):501-6. PubMed ID: 21378330
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells.
Miki Y; Akimoto J; Yokoyama S; Homma T; Tsutsumi M; Haraoka J; Hirano K; Beppu M
Biol Pharm Bull; 2013; 36(2):215-21. PubMed ID: 23196427
[TBL] [Abstract][Full Text] [Related]
7. Induction of Apoptosis by Functionalized Fullerene-based Sonodynamic Therapy in HL-60 cells.
Yumita N; Watanabe T; Chen FS; Momose Y; Umemura S
Anticancer Res; 2016 Jun; 36(6):2665-74. PubMed ID: 27272775
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with talaporfin sodium induces dose- and time-dependent apoptotic cell death in malignant meningioma HKBMM cells.
Ichikawa M; Akimoto J; Miki Y; Maeda J; Takahashi T; Fujiwara Y; Kohno M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():29-34. PubMed ID: 30389626
[TBL] [Abstract][Full Text] [Related]
9. Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage.
Liu L; Zhang Z; Xing D
Free Radic Biol Med; 2011 Jul; 51(1):53-68. PubMed ID: 21530645
[TBL] [Abstract][Full Text] [Related]
10. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.
Miki Y; Akimoto J; Moritake K; Hironaka C; Fujiwara Y
Lasers Med Sci; 2015 Aug; 30(6):1739-45. PubMed ID: 26109138
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
[TBL] [Abstract][Full Text] [Related]
13. Sonodynamically-induced in vitro cell damage enhanced by adriamycin.
Umemura S; Yumita N; Okano Y; Kaneuchi M; Magario N; Ishizaki M; Shimizu K; Sano Y; Umemura K; Nishigaki R
Cancer Lett; 1997 Dec; 121(2):195-201. PubMed ID: 9570359
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H
Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472
[TBL] [Abstract][Full Text] [Related]
15. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
[TBL] [Abstract][Full Text] [Related]
16. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K
Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677
[TBL] [Abstract][Full Text] [Related]
17. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
Spikes JD; Bommer JC
J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
19. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect.
Saito K; Mikuniya N; Aizawa K
Jpn J Cancer Res; 2000 May; 91(5):560-5. PubMed ID: 10835502
[TBL] [Abstract][Full Text] [Related]
20. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
